Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Crisis Response Action Plan: 48-Hour Framework Executive Summary The right course of action is clear: disclose transparently, protect patients immediately, and engage regulators urgently. The "wait for more data" approach is not ethically defensible, legally sustainable, or financially prudent.Read the full answer
As CEO, my overriding duty is to balance patient safety, legal/regulatory compliance, fiduciary responsibility, and long-term corporate survival. A 1-in-8,000 risk of liver failure is rare but severe, potentially fatal, and materially unexpected relative to the current label.Read the full answer